Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
“The use of targeted therapies, particularly those against the key mediator of angiogenesis, has the potential to improve outcomes for nonsmall cell lung cancer (NSCLC) patients.” When the
Continue reading– Patients with non-small-cell lung cancer (NSCLC) who don't have recurrence for 5 years after resection may not yet be free and clear. Some patients with certain tumor characteristics are at
Continue reading